TAMIFLU

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug TAMIFLU contains one active pharmaceutical ingredient (API):

1 Oseltamivir UNII 4A3O49NGEZ - OSELTAMIVIR PHOSPHATE

Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body. Read about Oseltamivir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TAMIFLU Powder for oral suspension	European Medicines Agency (EU)	MPI, EU: SmPC
TAMIFLU Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AH02	Oseltamivir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AH Neuraminidase inhibitors
Discover more medicines within J05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529205701116315, 529205703119311, 529205704115311
Country: CA	Health Products and Food Branch	Identifier(s): 02241472, 02304848, 02304856, 02381842
Country: EE	Ravimiamet	Identifier(s): 1110643, 1110654, 1367951, 1367962, 1593996
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02222001, 02222003, 02222004, 02222005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 079202, 106006, 106017, 402770
Country: FR	Base de données publique des médicaments	Identifier(s): 63209020, 63601338, 64086275, 68183914
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 130955, 130960, 146226, 215252, 42496
Country: HK	Department of Health Drug Office	Identifier(s): 46484, 55954, 56984, 56985, 57857, 62242, 63473, 63474, 64657
Country: IE	Health Products Regulatory Authority	Identifier(s): 46594, 46632, 46651, 90123
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4190, 6193, 6194
Country: IT	Agenzia del Farmaco	Identifier(s): 035943012, 035943024, 035943036, 035943048, 035943051
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250021M1027, 6250021R1024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011188, 1011189, 1030983, 1030986, 1071173
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 554M99
Country: NL	Z-Index G-Standaard	Identifier(s): 14808129
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 102709, 67482, 87165, 87173
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13745, 13746, 15485, 8961
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100113273, 100118514, 100179668, 100179697, 100259002
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64405001, W64406001
Country: SG	Health Sciences Authority	Identifier(s): 11403P, 13506P, 13507P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6993171
Country: US	FDA, National Drug Code	Identifier(s): 0004-0800, 0004-0801, 0004-0802, 0004-0822, 50090-0662
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/20.2.8/1020, 42/20.2.8/1021, 47/20.2.8/1194, A40/20.2.8/0578, A40/20.2.8/0579